62 related articles for article (PubMed ID: 10509049)
21. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
Yao B; Guo M; Pian H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
[TBL] [Abstract][Full Text] [Related]
22. [Progress in the field of hematology in the last 100 years: Medical history of chronic myelogenous leukemia].
Tomonaga M
Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2090-4. PubMed ID: 12187683
[No Abstract] [Full Text] [Related]
23. Expression of p210 bcr/abl increases hematopoietic progenitor cell radiosensitivity.
Santucci MA; Anklesaria P; Laneuville P; Das IJ; Sakakeeny MA; FitzGerald TJ; Greenberger JS
Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):831-6. PubMed ID: 8344852
[TBL] [Abstract][Full Text] [Related]
24. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
25. Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one.
Martinelli G; Amabile M; Giannini B; Terragna C; Ottaviani E; Soverini S; Saglio G; Rosti G; Baccarani M
Haematologica; 2002 Jul; 87(7):688-94; discussion 694. PubMed ID: 12091118
[TBL] [Abstract][Full Text] [Related]
26. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
27. Biology of BCR-ABL.
Chopra R; Pu QQ; Elefanty AG
Blood Rev; 1999 Dec; 13(4):211-29. PubMed ID: 10741897
[No Abstract] [Full Text] [Related]
28. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
29. 13cis- and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatment in vitro.
Benthin M; Dallmann I; Atzpodien J
Cancer Biother Radiopharm; 2001 Aug; 16(4):323-31. PubMed ID: 11603003
[TBL] [Abstract][Full Text] [Related]
30. All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia.
Zheng A; Savolainen ER; Koistinen P
Leuk Res; 1996 Mar; 20(3):243-8. PubMed ID: 8637219
[TBL] [Abstract][Full Text] [Related]
31. Molecular elimination of Ph1 clone in a chronic myelogenous leukemia patient with interferon-alpha alone.
Ishiyama K; Satoh S; Igarashi Y; Kumagai H; Yahagi A; Sasaki H
Leukemia; 1994 Dec; 8(12):2243-5. PubMed ID: 7808015
[No Abstract] [Full Text] [Related]
32. Establishment of novel cell lines derived from two patients with chronic myelogenous leukemia in blast crisis; IMS-BC1 and IMS-BC2 which exhibit markedly different sensitivity to apoptosis.
Nagamura F; Nagamura-Inoue T; Tojo A; Minamihisamatsu M; Tanabe T; Zaike Y; Tani K; Saisho H; Asano S
Int J Hematol; 1998 Apr; 67(3):283-94. PubMed ID: 9650450
[TBL] [Abstract][Full Text] [Related]
33. Liposome-associated retinoic acid. Increased in vitro antiproliferative effects on neoplastic cells.
Nastruzzi C; Walde P; Menegatti E; Gambari R
FEBS Lett; 1990 Jan; 259(2):293-6. PubMed ID: 2294018
[TBL] [Abstract][Full Text] [Related]
34. Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma.
Kast RE
Cancer Biol Ther; 2008 Oct; 7(10):1515-9. PubMed ID: 18769114
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the seed and the soil.
Deisseroth AB; Koenig J
J Clin Invest; 1994 Jul; 94(1):3. PubMed ID: 8040270
[No Abstract] [Full Text] [Related]
36. Effects of all-trans retinoic acid and interferon alpha in peripheral neuroectodermal tumor cell cultures and xenografts.
Rosolen A; Favaretto G; Masarotto G; Cavazzana A; Zanesco L; Frascella E
Int J Oncol; 1998 Nov; 13(5):943-9. PubMed ID: 9772283
[TBL] [Abstract][Full Text] [Related]
37. IL-6-receptor-mediated growth inhibition by all-trans retinoic acid but not by interferon-alpha in human myeloma cells.
Pulkki K; Neva M; Koskela K; Ollikainen H; Remes K; Pelliniemi TT
Ann N Y Acad Sci; 1995 Jul; 762():457-8. PubMed ID: 7668556
[No Abstract] [Full Text] [Related]
38. Retinoic acid effects on cell death and division patterns in experimental chick wing buds.
Frost SC; Hinchliffe JR
Prog Clin Biol Res; 1993; 383B():769-79. PubMed ID: 8115392
[No Abstract] [Full Text] [Related]
39. All-trans retinoic acid (ATRA) potentiates the in vitro inhibitory effects of IFN-alpha in parental (32D) and p210-bcr/abl transfected (LG7) murine myeloid cell lines.
Russo D; Tell G; Marin L; Tiribelli M; Santucci MA; Pucillo C
Haematologica; 1999 Oct; 84(10):955-7. PubMed ID: 10509049
[No Abstract] [Full Text] [Related]
40. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
